Tiffani Bailey Lash, Ph.D.
About Tiffani Bailey Lash, Ph.D.
Tiffani Bailey Lash, Ph.D., serves as Co Director of the NIH Rapid Acceleration of Diagnostics (RADxTech) Initiative and has held various positions at the National Institutes of Health since 2007, including Director of the NIH Technology Accelerator Challenge since 2019.
Work at National Institutes of Health
Tiffani Bailey Lash, Ph.D., holds multiple positions at the National Institutes of Health (NIH). She has served as the Director of the NIH Technology Accelerator Challenge (NTAC) since 2019. In this role, she focuses on accelerating the development of innovative technologies to improve health outcomes. Additionally, she has been a Health Scientist Administrator and Program Director since 2007, contributing to various health initiatives. Since 2020, she has also been the Co-Director of the NIH Rapid Acceleration of Diagnostics (RADxTech) Initiative, which aims to enhance COVID-19 testing capabilities through technology.
Education and Expertise
Tiffani Bailey Lash earned her Bachelor of Science degree in Chemistry from Hampton University, where she studied from 1998 to 2002. She then pursued a Ph.D. in Chemistry at North Carolina State University, completing her studies from 2002 to 2006. Her educational background provides a strong foundation in scientific research and technology development, which supports her work at the NIH.
Background
Before her tenure at the National Institutes of Health, Tiffani Bailey Lash worked as a Christine Mirzayan Science and Technology Policy Fellow at The National Academies in 2007. This role lasted for four months and involved engaging with science policy issues, further enhancing her expertise in the intersection of science and public policy.
Achievements
Throughout her career at the NIH, Tiffani Bailey Lash has played a significant role in various initiatives aimed at improving health technologies and diagnostics. Her leadership in the RADxTech Initiative has been crucial in addressing the challenges posed by the COVID-19 pandemic through innovative testing solutions. Her contributions to the NIH Technology Accelerator Challenge also reflect her commitment to advancing health technology.